Endometrioma
43
10
10
17
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.3%
1 terminated out of 43 trials
94.4%
+7.9% vs benchmark
7%
3 trials in Phase 3/4
0%
0 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 17 completed trials
Clinical Trials (43)
Role of Anti Mullerian Hormone for Ovarian Reserve Determination of Preoperative and Postoperative Endometrioma Patients
Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis
Laparoscopic Sclerotherapy for the Management of Ovarian Endometriomas
Effect of Dienogest in Symptomatic Endometrioma in Comparison to Combined Oral Contraceptive Pill.
Effect of Elagolix in Symptomatic Endometrioma in Comparison to Combined Oral Contraceptive Pill.
Effect of Management of the Endometrioma on Ovarian Reserve
Ablative Technique For Ovarian Preservation In Endometrioma
PET/MRI for Evaluation of Endometriosis
Mechanisms of Uterine Fluid Absorption During Early Pregnancy ( ELF Study)
The Therapy of Large Endometrioma
Endometrioma Sclerotherapy and Ovarian Preservation
Endometrioma Ethanol Sclerotherapy - Prospective Cohort Study Protocol
Estetrol/Drospirenone to Reduce the Average Size of Endometriomas
Conservative Endometrioma Surgery
Ethanol Sclerotherapy Prior to ART
Hemostatic Measures During Laparoscopic Cystectomy for Endometrioma
Laparoscopic Therapy of Endometrioma: Sclerotherapy vs Cystectomy in Patients With Unfinished Reproductive Plans
Two-session Catheter-directed Sclerotherapy Using Ethanol for Endometrioma
Evaluation of Ovarian Reserve and Recurrence Rate After DWLS Diode Laser OMA Vaporization
Optimum Menstrual Cycle Time for Endometrioma Excision